Q-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks
Journal of Drugs in Dermatology · 2026-11-01 · 25 (11) · 1074-1075
DOI: 10.36849/jdd.9397 ↗At a glance
Fallbericht in Journal of Drugs in Dermatology, published online on 2026-10-01. Written by Danny Linggonegoro and 2 co-authors. Major MEDLINE topics: Lasers, Solid-State, Lichen Planus, Hyperpigmentation.
Abstract (original language)
Lichen planus pigmentosus (LPP) is a challenging pigmentary disorder that often affects extrafacial sites, yet most published data on laser treatment focus on facial involvement. We report 3 cases of biopsy-proven LPP treated with Q-switched neodymium: yttrium aluminum garnet (QS Nd:YAG) laser involving both facial and extrafacial areas. All patients experienced improvement in facial LPP, while outcomes on the neck, shoulders, and trunk were more variable. One patient developed koebnerized vitiligo after laser treatment to the neck, underscoring the need for caution in patients with underlying or suspected vitiligo. These cases highlight both the therapeutic potential and limitations of QS Nd:YAG lasers for extrafacial LPP and suggest that lower fluence approaches may offer safer alternatives in sensitive areas. .
Subjects
MeSH terms (MEDLINE)
Cite
APA
Linggonegoro, D., Bandali, T., & Kibbi, N. (2026). Q-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks. Journal of Drugs in Dermatology, 25(11), 1074-1075. https://doi.org/10.36849/jdd.9397
Vancouver
Linggonegoro D, Bandali T, Kibbi N. Q-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks. Journal of Drugs in Dermatology. 2026;25(11):1074-1075. doi:10.36849/jdd.9397
BibTeX
@article{Linggonegoro2026,
author = {Linggonegoro, Danny and Bandali, Tarek and Kibbi, Nour},
title = {Q-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {11},
pages = {1074--1075},
doi = {10.36849/jdd.9397}
}
EUVIMED